HAIN:NASDAQThe Hain Celestial Group, Inc. Analysis
Data as of 2026-06-21 - not real-time
$0.61
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading at $0.6059, well below its 20‑day SMA of $0.7065 and the 200‑day SMA of $1.059, indicating a strong bearish price trend. The RSI sits at 38, suggesting limited upside momentum, while the MACD histogram is negative and the MACD signal is flagged as bearish. Volume is increasing, but the 30‑day volatility is extreme at 81.6% and the computed beta of 1.77 points to heightened market sensitivity. On the fundamentals side, revenue has contracted 13% year‑over‑year, profit margins are deeply negative (-35.5%), and the company carries a staggering debt‑to‑equity ratio of 276, with cash of only $46.2 M against $595.8 M of debt. Despite these headwinds, the DCF model implies a fair value of $11.83, translating to a calculated upside of roughly 132%, and the forward PE of 6.73 is modest. Recent Q3 results delivered a surprise EPS beat and sparked a 12% pre‑market rally, highlighting that the turnaround plan is gaining traction. However, the max drawdown of -73% and historically weak profitability keep the risk profile elevated. The combination of deep discount to intrinsic value and improving cash generation offers a compelling, albeit high‑risk, investment narrative.
Given the stark valuation gap, the stock may be severely undervalued, but the bearish technical setup, volatile price action, and fragile balance sheet suggest caution. The earnings beat provides a short‑term catalyst, yet the underlying financial health and high leverage constrain confidence. Investors should weigh the potential upside against the substantial downside risk and consider a phased entry strategy aligned with further operational improvements.
Given the stark valuation gap, the stock may be severely undervalued, but the bearish technical setup, volatile price action, and fragile balance sheet suggest caution. The earnings beat provides a short‑term catalyst, yet the underlying financial health and high leverage constrain confidence. Investors should weigh the potential upside against the substantial downside risk and consider a phased entry strategy aligned with further operational improvements.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Recent EPS beat and 12% rally
- Bearish technical indicators (SMA, MACD)
- High volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside of ~132% versus current price
- Improving cash generation and turnaround execution
- Modest forward PE and low price‑to‑book
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount to intrinsic value
- Potential recovery of margins as turnaround progresses
- Strategic positioning in organic/natural food market
Key Metrics & Analysis
Financial Health
Revenue Growth-13.30%
Profit Margin-35.47%
P/E Ratio6.7
ROE-113.04%
ROA1.39%
Debt/Equity276.41
P/B Ratio0.3
Op. Cash Flow$64.2M
Free Cash Flow$122.9M
Technical Analysis
TrendBearish
RSI38.2
Support$0.57
Resistance$0.86
MA 20$0.71
MA 50$0.76
MA 200$1.06
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$11.83
Target Price$1.41
Upside/Downside132.05%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.77
Volatility81.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.